Nicar Laboratories Inc.

A recognized leader in the field of probiotics with our PROBACLAC family of products, Nicar is fully cognizant of the importance of validating the clinical safety and effectiveness of each of our products in order to earn the support of healthcare professionals. All of our R&D efforts and new product development processes are established in keeping with these fundamentals. Our team comprises biochemists, nutritionists, pharmacists and experienced sales professionals – all of whom are driven by the same ambition: contributing to the health of consumers.

Our natural products must be approved by Health Canada before we can market them, and every one of our products receives a product licence with an NPN issued by Canadian government authorities. We are planning to diversify our corporate activities and broaden the scope of our marketing portfolio in the near future with the launch of our TRIAMEG^TM OMEGA3 family of products. The five original formulas in this line are pharmaceutical grade, and have been issued NPNs by Health Canada. They contain rich concentrations of EPA and DHA, and have been clinically validated for human use for a variety of health applications. In parallel with the launch of these products, we are actively working toward the development of innovative new products and solutions aimed at improving the health of consumers.

Now that we have completed our cross-Canada expansion, our focus turns to international business development, particularly in the United States, where we have recently forged a number of new partnerships.

In conclusion, let me assure you that, above all, the members of the Nicar Laboratories family are passionate about doing everything in their power to respond to the needs of people who desire to improve their quality of life. Without a doubt, their passion represents your ultimate guarantee of quality.